Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice
about
Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3Identifying the association of contrast enhancement with vascular endothelia growth factor expression in anaplastic gliomas: a volumetric magnetic resonance imaging analysisEGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.Personalized anticancer therapy selection using molecular landscape topology and thermodynamics.Long noncoding RNA profiles reveal three molecular subtypes in glioma.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.
P2860
Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cells with intense EGFR staini ...... in neuropathological practice
@en
Cells with intense EGFR staini ...... in neuropathological practice.
@nl
type
label
Cells with intense EGFR staini ...... in neuropathological practice
@en
Cells with intense EGFR staini ...... in neuropathological practice.
@nl
prefLabel
Cells with intense EGFR staini ...... in neuropathological practice
@en
Cells with intense EGFR staini ...... in neuropathological practice.
@nl
P2093
P2860
P356
P1433
P1476
Cells with intense EGFR staini ...... in neuropathological practice
@en
P2093
Damien Ambrosetti
Eric Fontas
Fabien Almairac
Fanny Burel-Vandenbos
Jean-François Michiels
Laurent Turchi
Maxime Benchetrit
Thierry Virolle
Valérie Rigau
Zoe Pedeutour
P2860
P304
P356
10.1093/NEUONC/NOT094
P577
2013-08-09T00:00:00Z